Myron W. Shulgan

Executive

US·SEC (Form 4)

Drugs Made In America Acquisition Corp.Drugs Made In America Acquisition II Corp.

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 02 Oct 2025 for Drugs Made In America Acquisition II Corp.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Myron W. Shulgan: trading record in brief

Myron W. Shulgan discloses dealings in 2 companies, chiefly Drugs Made In America Acquisition Corp. and Drugs Made In America Acquisition II Corp. Over a trading history stretching from 29 January 2025 to 26 September 2025, the count stands at 2 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The record was last updated on 2 October 2025 with a transaction in Drugs Made In America Acquisition II Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.